Evidence map›Paper›PMID 26031423›Full record

ArticleDigestive diseases and sciences2016

Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients.

XiangWu Jiang, Fei Gao, Yan Ma, ShuFen Feng, XueLian Liu, HongKe Zhou

Open access · hybridAbstract read
In one paragraph

Article in Digestive diseases and sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

XiangWu JiangDepartment of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China. jxr112233@126.com.
Fei GaoDepartment of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Yan MaDepartment of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
ShuFen FengDepartment of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
XueLian LiuDepartment of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
HongKe ZhouDepartment of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
First Affiliated Hospital of Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this study was to estimate the feasibility and therapeutic effectiveness of percutaneous microwave ablation in the treatment of hypersplenism in cirrhosis.

methodsForty-one cirrhosis patients with hypersplenism were treated with ultrasonography-guided percutaneous microwave ablation between February 2007 and August 2011. Peripheral blood cell counts, portal vein diameter, splenic vein diameter, and blood flow of splenic vein were evaluated before and after the operation, and complications of the treatment were also investigated. All patients were followed up for 24 months.

resultsThe levels of platelets and white blood cells were increased, while the splenic vein diameter narrowed gradually after the therapy and 24 months later. Moreover, patients received percutaneous microwave ablation had much lower splenic venous flow velocity. The portal vein diameter did not change significantly 6 months after the treatment, although it narrowed gradually within 3 months after the treatment. Furthermore, no complications such as uncontrollable bleeding, splenic abscess, spleen rupture, and damage in surrounding organ happened after the therapy.

conclusionsGraded percutaneous microwave ablation, as a minimally invasive therapy, could damage the spleen, increase the levels of platelets and white blood cells, and reduce portal hypertension effectively without serious complications. Percutaneous microwave ablation is an effective, safe, and feasible method for cirrhosis patients with hypersplenism.

Indexed as

Ablation TechniquesFeasibility StudiesFemaleHumansHypersplenismHypertension, PortalLeukocyte CountLiver CirrhosisMaleMicrowavesMiddle AgedPlatelet CountProspective StudiesTime FactorsTomography, X-Ray ComputedTreatment OutcomeCirrhosisHypersplenismMinimally invasive therapyPercutaneous microwave ablation

Identifiers

PMID26031423
PMCPMC4700057
OpenAlexW562889519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.